Big Movers – North American Palladium, Avanir Pharmaceuticals Inc, Gogo Inc

134

StocksNorth American Palladium Ltd (USA) (NYSEMKT:PAL) amends the conversion price of its previously announced proposed public offering of up to $32 million of 7.5% convertible unsecured subordinated debentures and associated warrants .The initial conversion price of the first tranche debentures will be CAD0.635 and the initial exercise price of the first tranche warrants will be CAD0.762 (the exercise of which remains subject to disinterested shareholder approval). North American Palladium Ltd (USA) (NYSEMKT:PAL) shares are trading at $0.445.

Avanir Pharmaceuticals Inc (NASDAQ:AVNR) has announced submission of NDA for AVP-825 for the Acute Treatment of Migraine. Avanir Pharmaceuticals Inc (NASDAQ:AVNR) has announced that it has submitted a New Drug Application (:NDA) to the U.S. Food and Drug Administration (:FDA) for approval of AVP-825, its innovative Breath Powered investigational drug-device combination product for the acute treatment of migraine. Avanir Pharmaceuticals Inc (NASDAQ:AVNR) shares rae trading at $3.90.

Gogo Inc (NASDAQ:GOGO) to offer Gogo Vision on JAL’s domestic fleet. Gogo Inc (NASDAQ:GOGO) announces that it will add Gogo Vision to Japan Airlines’ entire domestic fleet. Gogo recently announced a partnership with JAL to provide in-flight Internet on the same fleet. Gogo Vision is Gogo’s wireless in-flight entertainment service that allows passengers to rent movies and television shows and stream them to their own Wi-Fi enabled laptops or tablets. The new service, as well as Internet connectivity, is expected to be available to JAL passengers beginning in the summer of 2014. Gogo Inc (NASDAQ:GOGO) shares are trading at $20.84.

Comments